{
    "key": "2013-0488",
    "name": "#2 @ 16 yr - 4 days, MCV4",
    "cdcTestId": "2013-0488",
    "changedInVersion": "1.6",
    "dateAdded": "2013-01-01T00:00:00",
    "dateUpdated": "2020-06-01T09:53:37.143",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "114",
                "dateAdministered": "2015-08-17T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PMC",
                "vaccineName": "MENACTRA"
            },
            {
                "cvx": "114",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PMC",
                "vaccineName": "MENACTRA"
            }
        ],
        "seriesStatus": "Complete"
    },
    "evaluationTestType": "Age: At Absolute Minimum",
    "forecast": {
        "earliestDate": "0001-01-01T00:00:00",
        "forecastNum": "-",
        "pastDueDate": "0001-01-01T00:00:00",
        "recommendedDate": "0001-01-01T00:00:00"
    },
    "forecastTestType": "Not recommended: series complete",
    "generalDescription": "This test case describes when dose #2 of a Mening vaccine is given at 16 years - 4 days, that the dose is considered valid.  The series is complete. ",
    "patient": {
        "dob": "2004-08-17T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "114",
                "dateAdministered": "2015-08-17T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PMC",
                "vaccineName": "MENACTRA"
            },
            {
                "cvx": "114",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PMC",
                "vaccineName": "MENACTRA"
            }
        ]
    },
    "reasonForChange": "v1.6: Updated Test case to reflect new absolute minimum age on dose 2 based on EIPB clarification",
    "testcaseName": "#2 @ 16 yr - 4 days, MCV4",
    "vaccineGroup": "MCV"
}